AR005368A1 - HETEROARILCARBOXAMIDES COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE APPLICATION OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES, A METHOD FOR TREATING DISEASES WITH SUCH COMPOUNDS AND THE PROCEDURES FOR PREPARING SUCH COMPOUNDS. - Google Patents
HETEROARILCARBOXAMIDES COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE APPLICATION OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES, A METHOD FOR TREATING DISEASES WITH SUCH COMPOUNDS AND THE PROCEDURES FOR PREPARING SUCH COMPOUNDS.Info
- Publication number
- AR005368A1 AR005368A1 ARP970100041A ARP970100041A AR005368A1 AR 005368 A1 AR005368 A1 AR 005368A1 AR P970100041 A ARP970100041 A AR P970100041A AR P970100041 A ARP970100041 A AR P970100041A AR 005368 A1 AR005368 A1 AR 005368A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- methylene
- disease
- heteroarilcarboxamides
- medicines
- Prior art date
Links
Abstract
Compuestos de fórmula (I) y sales farmacéuticamente aceptables de los mismos en los cuales A es metileno u O; B es metileno u O; g es 0,1,2,3, o 4;R1 es unn sustituyente optativo; U es una cadena de alquileno opcionalmente sustituída porun o o má alquilos; Q representa un grupo divalente que contieneátomos de nitrógeno; y T representa CO HET, tienen utilidad en el tratamiento de afecciones del sistema nervioso central, por ejemplo depresión, ansiedad,psicosis (por ejemploesquizofreni a), disquinesia tardía, mal de Parkinson, obesidad, hipertensión, síndrome de Tourette, disfunción sexual, drogadicción,abuso de drogas, anomalías cognoscitivas, Mal de Alzheimer, demencia senil, conducta obscesiva-compulsiva,ataques de páni co, fobias sociales, anomalías enel comer y anorexia, afecciones cardiovasculares y cerebrovasculares, diabetes mellitus no insulino-dependiente, hiperglicemia, constipación, arritmiaa,afecciones del sistema neuroendócrino, estrés,hipertrofia prost ática, y espasticidad.Compounds of formula (I) and pharmaceutically acceptable salts thereof in which A is methylene or O; B is methylene or O; g is 0,1,2,3, or 4, R1 is an optional substituent n; U is an alkylene chain optionally substituted by one or more alkyls; Q represents a divalent group containing nitrogen atoms; and T represents CO HET, they have utility in the treatment of central nervous system conditions, for example depression, anxiety, psychosis (for example schizophrenia), tardive dyskinesia, Parkinson's disease, obesity, hypertension, Tourette syndrome, sexual dysfunction, drug addiction , drug abuse, cognitive abnormalities, Alzheimer's disease, senile dementia, obstructive-compulsive behavior, panic attacks, social phobias, eating abnormalities and anorexia, cardiovascular and cerebrovascular conditions, non-insulin-dependent diabetes mellitus, hyperglycemia, constipation, arrhythmia, neuroendocrine system disorders, stress, prostatic hypertrophy, and spasticity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP970100041A AR005368A1 (en) | 1997-01-06 | 1997-01-06 | HETEROARILCARBOXAMIDES COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE APPLICATION OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES, A METHOD FOR TREATING DISEASES WITH SUCH COMPOUNDS AND THE PROCEDURES FOR PREPARING SUCH COMPOUNDS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP970100041A AR005368A1 (en) | 1997-01-06 | 1997-01-06 | HETEROARILCARBOXAMIDES COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE APPLICATION OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES, A METHOD FOR TREATING DISEASES WITH SUCH COMPOUNDS AND THE PROCEDURES FOR PREPARING SUCH COMPOUNDS. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR005368A1 true AR005368A1 (en) | 1999-04-28 |
Family
ID=51929291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970100041A AR005368A1 (en) | 1997-01-06 | 1997-01-06 | HETEROARILCARBOXAMIDES COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE APPLICATION OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES, A METHOD FOR TREATING DISEASES WITH SUCH COMPOUNDS AND THE PROCEDURES FOR PREPARING SUCH COMPOUNDS. |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR005368A1 (en) |
-
1997
- 1997-01-06 AR ARP970100041A patent/AR005368A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI961016A (en) | Bicyclic aromatic compounds as therapeutic substances | |
| RU2006111469A (en) | CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS | |
| BR0307351A (en) | Compound, pharmaceutical composition, method for treating a p38 kinase activity-mediated or cytokine-mediated condition or condition produced by p38 kinase activity, use of a compound, and process for preparing a compound | |
| ATE197672T1 (en) | MEDICINAL PRODUCTS FOR NERVOUS DISEASES | |
| AR041297A1 (en) | DERIVATIVES OF 4-PIRROLIDINO- FENIL- BENCIL ETER | |
| NO980129D0 (en) | Heterocyclyl carboxamide derivatives and their use as therapeutic agents | |
| YU30902A (en) | Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof | |
| NO940163D0 (en) | Tricyclic condensed heterocyclic compounds, their preparation and use | |
| BR9714237A (en) | Compounds, use of a compound, processes for treating depression, anxiety, psychosis, tardive dyskinesia, parkinson's disease, obesity, hypertension, tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive illness, alzheimer's disease, senile dementia , obsessive compulsive behavior, panic attacks, social phobias, diseases and food anorexia, cardiovascular and cerebrovascular diseases, diabetes mellitus not dependent on insulin, hyperglycemia, constipation, arrhythmia, diseases of the neuroendocrine system, tension and spasticity in humans and for preparation of compounds, and pharmaceutical composition. | |
| Mokrosz et al. | 8-[4-[2-(1, 2, 3, 4-tetrahydroisoquinolinyl)] butyl]-8-azaspiro [4.5] decane-7, 9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone | |
| AR005368A1 (en) | HETEROARILCARBOXAMIDES COMPOUNDS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE APPLICATION OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES, A METHOD FOR TREATING DISEASES WITH SUCH COMPOUNDS AND THE PROCEDURES FOR PREPARING SUCH COMPOUNDS. | |
| DE60213576D1 (en) | ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINOi2,3-FOXINOXALINE | |
| AR011358A1 (en) | DERIVATIVES OF BENZO [E] ISOINDOL AND BENZO [H] ISOQUINOLINE, THEIR USE, A PROCEDURE FOR THEIR PREPARATION AND CONTAINING MEDICINES | |
| BR9910927A (en) | Compound, pharmaceutical compositions, process for treating depression, anxiety, psychosis, parkinson's disease, obesity, hypertension, tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, alzheimer's disease, senile dementia, obsessive-compulsive behavior , panic attacks, eating ailments, anorexia, cardiovascular and cerebrovascular disorders, migraine, non-insulin dependent diabetes mellitus, hyperglycemia, constipation, arrhythmia, disorders of the neuroendocrine system, tension, prostatic hypertrophy, extrapyramidal symptoms induced by drugs or spasticity, use of a compound, and, process for preparing the compound | |
| DE59606725D1 (en) | SUBSTITUTED PHENYLAMIDINE, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF | |
| AR042379A1 (en) | NEW CYCLLOBUTAINDOL CARBOXAMIDE COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR019841A1 (en) | A COMPOUND DERIVED FROM N- [3- [2 - [(2,3-DIHIDRO-1H-INDEN-2-IL) ALQUILAMINO] -ETILFENIL] CARBOXAMIDE, A MEDICINAL PRODUCT THAT CONSISTS OF SUCH COMPOUND AND COMPOSITION COMPOSITION. | |
| TH19066A (en) | Method for inhibiting smooth muscle cell proliferation and stenosis | |
| RU2000133316A (en) | N-BENZODHYOXANYLMETHYL-1-PIPERIDYL-METHYLAMINES possess an affinity for 5-HT receptors | |
| TH63693A (en) | Isocquinoline derivatives | |
| TH65470A (en) | Pyrolidone derivatives that are MAOB inhibitors |